Pharming Group N.V. Announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was EUR 134.714 million compared to EUR 123.358 million a year ago. Operating income was EUR 51.145 million compared to EUR 42.684 million a year ago. Net income was EUR 25.596 million compared to EUR 24.056 million a year ago. Basic earnings per share from continuing operations was EUR 0.04 compared to EUR 0.038 a year ago. Diluted earnings per share from continuing operations was EUR 0.035 compared to EUR 0.036 a year ago.